|
1
|
Iacob G and Dinca EB: Current data and
strategy in glioblastoma multiforme. J Med Life. 2:386–393.
2009.PubMed/NCBI
|
|
2
|
Garten A, Schuster S, Penke M, Gorski T,
de Giorgis T and Kiess W: Physiological and pathophysiological
roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 11:535–546.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Imai S, Armstrong CM, Kaeberlein M and
Guarente L: Transcriptional silencing and longevity protein Sir2 is
an NAD-dependent histone deacetylase. Nature. 403:795–800. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kim MY, Mauro S, Gevry N, Lis JT and Kraus
WL: NAD+-dependent modulation of chromatin structure and
transcription by nucleosome binding properties of PARP-1. Cell.
119:803–814. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Van Gool F, Galli M, Gueydan C, Kruys V,
Prevot PP, Bedalov A, Mostoslavsky R, Alt FW, De Smedt T and Leo O:
Intracellular NAD levels regulate tumor necrosis factor protein
synthesis in a sirtuin-dependent manner. Nat Med. 15:206–210. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shackelford RE, Mayhall K, Maxwell NM,
Kandil E and Coppola D: Nicotinamide phosphoribosyltransferase in
malignancy: A review. Genes Cancer. 4:447–456. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin SJ and Guarente L: Nicotinamide
adenine dinucleotide, a metabolic regulator of transcription,
longevity and disease. Curr Opin Cell Biol. 15:241–246. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sebastian C, Satterstrom FK, Haigis MC and
Mostoslavsky R: From sirtuin biology to human diseases: An update.
J Biol Chem. 287:42444–42452. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiarugi A, Dolle C, Felici R and Ziegler
M: The NAD metabolome-a key determinant of cancer cell biology. Nat
Rev Cancer. 12:741–752. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chinnadurai G: The transcriptional
corepressor CtBP: A foe of multiple tumor suppressors. Cancer Res.
69:731–734. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malavasi F, Deaglio S, Funaro A, Ferrero
E, Horenstein AL, Ortolan E, Vaisitti T and Aydin S: Evolution and
function of the ADP ribosyl cyclase/CD38 gene family in physiology
and pathology. Physiol Rev. 88:841–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Burkle A and Virag L: Poly(ADP-ribose):
PARadigms and PARadoxes. Mol Aspects Med. 34:1046–1065. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodgers JT, Lerin C, Gerhart-Hines Z and
Puigserver P: Metabolic adaptations through the PGC-1 alpha and
SIRT1 pathways. FEBS Lett. 582:46–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van der Horst A, Tertoolen LG, de
Vries-Smits LM, Frye RA, Medema RH and Burgering BM: FOXO4 is
acetylated upon peroxide stress and deacetylated by the longevity
protein hSir2(SIRT1). J Biol Chem. 279:28873–28879. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bordone L, Motta MC, Picard F, Robinson A,
Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A,
et al: Sirt1 regulates insulin secretion by repressing UCP2 in
pancreatic beta cells. PLoS Biol. 4:e312006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maldi E, Travelli C, Caldarelli A,
Agazzone N, Cintura S, Galli U, Scatolini M, Ostano P, Miglino B,
Chiorino G, et al: Nicotinamide phosphoribosyltransferase (NAMPT)
is over-expressed in melanoma lesions. Pigment Cell Melanoma Res.
26:144–146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang WS, Chen CN, Sze CI and Teng CC:
Visfatin induces stromal cell-derived factor-1 expression by β1
integrin signaling in colorectal cancer cells. J Cell Physiol.
228:1017–1024. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Olesen UH, Hastrup N and Sehested M:
Expression patterns of nicotinamide phosphoribosyltransferase and
nicotinic acid phosphoribosyltransferase in human malignant
lymphomas. APMIS. 119:296–303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reddy PS, Umesh S, Thota B, Tandon A,
Pandey P, Hegde AS, Balasubramaniam A, Chandramouli BA, Santosh V,
Rao MR, et al: PBEF1/NAmPRTase/Visfatin: A potential malignant
astrocytoma/glioblastoma serum marker with prognostic value. Cancer
Biol Ther. 7:663–668. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shai R, Shi T, Kremen TJ, Horvath S, Liau
LM, Cloughesy TF, Mischel PS and Nelson SF: Gene expression
profiling identifies molecular subtypes of gliomas. Oncogene.
22:4918–4923. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bredel M, Bredel C, Juric D, Harsh GR,
Vogel H, Recht LD and Sikic BI: Functional network analysis reveals
extended gliomagenesis pathway maps and three novel MYC-interacting
genes in human gliomas. Cancer Res. 65:8679–8689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun L, Hui AM, Su Q, Vortmeyer A,
Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey
R, et al: Neuronal and glioma-derived stem cell factor induces
angiogenesis within the brain. Cancer Cell. 9:287–300. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murat A, Migliavacca E, Gorlia T, Lambiv
WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven
MC, et al: Stem cell-related ‘self-renewal’ signature and high
epidermal growth factor receptor expression associated with
resistance to concomitant chemoradiotherapy in glioblastoma. J Clin
Oncol. 26:3015–3024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hufton SE, Moerkerk PT, Brandwijk R, de
Bruine AP, Arends JW and Hoogenboom HR: A profile of differentially
expressed genes in primary colorectal cancer using suppression
subtractive hybridization. Febs Lett. 463:77–82. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakajima TE, Yamada Y, Hamano T, Furuta K,
Gotoda T, Katai H, Kato K, Hamaguchi T and Shimada Y: Adipocytokine
levels in gastric cancer patients: Resistin and visfatin as
biomarkers of gastric cancer. J Gastroenterol. 44:685–690. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakajima TE, Yamada Y, Hamano T, Furuta K,
Matsuda T, Fujita S, Kato K, Hamaguchi T and Shimada Y:
Adipocytokines as new promising markers of colorectal tumors:
Adiponectin for colorectal adenoma, and resistin and visfatin for
colorectal cancer. Cancer Sci. 101:1286–1291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gujar AD, Le S, Mao DD, Dadey DY, Turski
A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, et al: An
NAD+-dependent transcriptional program governs
self-renewal and radiation resistance in glioblastoma. Proc Natl
Acad Sci USA. 113:E8247–E8256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YC, Yang YH, Su JH, Chang HL, Hou MF
and Yuan SS: High visfatin expression in breast cancer tissue is
associated with poor survival. Cancer Epidemiol Biomarkers Prev.
20:1892–1901. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bi TQ, Che XM, Liao XH, Zhang DJ, Long HL,
Li HJ and Zhao W: Overexpression of Nampt in gastric cancer and
chemopotentiating effects of the Nampt inhibitor FK866 in
combination with fluorouracil. Oncol Rep. 26:1251–1257.
2011.PubMed/NCBI
|
|
32
|
Shackelford RE, Bui MM, Coppola D and
Hakam A: Over-expression of nicotinamide phosphoribosyltransferase
in ovarian cancers. Int J Clin Exp Pathol. 3:522–527.
2010.PubMed/NCBI
|
|
33
|
Wang B, Hasan MK, Alvarado E, Yuan H, Wu H
and Chen WY: NAMPT overexpression in prostate cancer and its
contribution to tumor cell survival and stress response. Oncogene.
30:907–921. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang H, Yang T, Baur JA, Perez E, Matsui
T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A,
et al: Nutrient-sensitive mitochondrial NAD+ levels
dictate cell survival. Cell. 130:1095–1107. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jung J, Kim LJ, Wang X, Wu Q, Sanvoranart
T, Hubert CG, Prager BC, Wallace LC, Jin X, Mack SC and Rich JN:
Nicotinamide metabolism regulates glioblastoma stem cell
maintenance. JCI insight. 2(pii): 900192017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Venkateshaiah SU, Khan S, Ling W, Bam R,
Li X, van Rhee F, Usmani S, Barlogie B, Epstein J and Yaccoby S:
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell
growth and osteoclast activity. Exp Hematol. 41:547–557.e2. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Revollo JR, Grimm AA and Imai S: The
regulation of nicotinamide adenine dinucleotide biosynthesis by
Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol.
23:164–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
